Cite

HARVARD Citation

    Tsai, Y. et al. (2019). HER2 immunohistochemical scores provide prognostic information for patients with HER2‐type invasive breast cancer. Histopathology. 74 (4), pp. 578-586. [Online]. 
  
Back to record